The ubiquitin editing enzyme A20 (TNFAIP3) is upregulated during permanent middle cerebral artery occlusion but does not influence disease outcome

por Mc Guire, C, Rahman, M, Schwaninger, M, Beyaert, R, van Loo, G
Publicado 2013

A20 deficiency sensitizes pancreatic beta cells to cytokine-induced apoptosis in vitro but does not influence type 1 diabetes development in vivo

por Catrysse, L, Fukaya, M, Sze, M, Meyerovich, K, Beyaert, R, Cardozo, A K, van Loo, G
Publicado 2015

A20/TNFAIP3 heterozygosity predisposes to behavioral symptoms in a mouse model for neuropsychiatric lupus

por Daems, C., Sékulic, M., Vulsteke, V., van Loo, G., D’Hooge, R., Callaerts-Végh, Z., Callaerts, P.
Publicado 2019

A20 prevents chronic liver inflammation and cancer by protecting hepatocytes from death

por Catrysse, L, Farhang Ghahremani, M, Vereecke, L, Youssef, S A, Mc Guire, C, Sze, M, Weber, A, Heikenwalder, M, de Bruin, A, Beyaert, R, van Loo, G
Publicado 2016